Trials / Terminated
TerminatedNCT02875704
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 77 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.
Detailed description
People with Stargardt disease, age related macular degeneration (AMD) and diabetic retinopathy (DR) have decrease in central vision from damage to photoreceptors. One of the mechanisms causing damage is high levels of oxygen in the eye. This damage produces specific biomarkers that can be measured in eye fluid (aqueous humor). In this study, these biomarkers will be assessed in people with Stargardt disease, age related macular degeneration and diabetic retinopathy, compared to controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Anterior Chamber (AC) Tap | Aqueous Samples will be collected for measurement of biomarkers |
Timeline
- Start date
- 2017-01-03
- Primary completion
- 2022-06-06
- Completion
- 2022-09-22
- First posted
- 2016-08-23
- Last updated
- 2022-09-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02875704. Inclusion in this directory is not an endorsement.